Manufacture

While contamination issues continue to limit the potential of gene therapy, scientists can no longer afford to ignore the best detection methods.

I explore recent cases of pediatric cough medicines contaminated with diethylene glycol.

Transporting temperature-sensitive pharmaceuticals is only going to become more challenging as we face the realities of the climate crisis.

We interviewed ScaleReady’s Global Commercial Director Josh Ludwig to learn more about manufacturing in the Cell and Gene Industry

Our latest eBook gives a snapshot of innovation in cell and gene therapies

Both the FDA and Pfizer have released statements in the aftermath of the North Carolina tornado.

Watch our roundtable discussion featuring experts from Terumo Blood and Cell Technologies, Orgenesis, ScaleReady, and BioBridge Global

Innovation begins as an idea, but partnerships give it life. We speak to Joey Glassco, LLS Health, about Apisolex, our 2022 Innovation Awards winner.

With the right technology in place, manufacturers can avoid the supply shortfalls experienced during respiratory season

Sitting Down With… Theresa Heah, CEO, Intergalactic Therapeutics, Cambridge, Massachusetts